| 标题 |
MM-739: Daratumumab + Bortezomib, Lenalidomide, and Dexamethasone (D-VRd) vs VRd in Transplant-Ineligible (TIE)/Transplant-Deferred (TD) Newly Diagnosed Multiple Myeloma (NDMM): Phase 3 CEPHEUS Trial Cytogenetic Subgroup Analysis |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lymphoma Myeloma and Leukemia 作者:Saad Z. Usmani; Nizar J. Bahlis; Thierry Facon; Sonja Zweegman; Christopher P. Venner; et al 出版日期:2025-08-28 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)